Literature analysis of cutaneous adverse reactions induced by tislelizumab

CONCLUSIONS: Tislelizumab-related cutaneous adverse reactions mostly occur after several days to months of treatment. In clinical practice, evaluation and monitoring should be strengthened. More attention should be paid to erythema and rashes, which may be signs of serious adverse skin reactions. Early detection and intervention can ensure the safe use of drugs and provide greater clinical benefits to patients.PMID:37909927 | DOI:10.1080/15569527.2023.2275028

Source: Cutaneous and Ocular Toxicology - November 1, 2023 Category: Toxicology Authors: Qingli Guo Lili Jin Tingting Zhang Ruihao Gao Kaili Zou Min Fu Hengtai Bi Junyao Zhang Min Zhang Source Type: research